Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional …
Over the last 12 months, insiders at Venus Concept Inc. have bought $0 and sold $370,162 worth of Venus Concept Inc. stock.
On average, over the past 5 years, insiders at Venus Concept Inc. have bought $4.96M and sold $556,260 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 60,000 shares for transaction amount of $13,200 was made by PORTARO ROSS (President Global Sales) on 2022‑11‑21.
2024-10-02 | Sale | 10 percent owner | 94,553 1.178% | $0.53 | $50,160 | -12.65% | ||
2024-10-01 | Sale | 10 percent owner | 140,214 1.9599% | $0.60 | $83,455 | -21.04% | ||
2024-09-30 | Sale | 10 percent owner | 71,368 1.0809% | $0.64 | $46,025 | -25.85% | ||
2024-06-11 | Sale | 10 percent owner | 102,717 1.757% | $1.20 | $122,829 | -47.94% | ||
2024-06-07 | Sale | 10 percent owner | 55,382 1.1453% | $1.22 | $67,692 | -37.88% | ||
2022-11-29 | Sale | director | 51,431 0.0049% | $0.24 | $12,503 | -34.44% | ||
2022-11-28 | Sale | director | 51,428 0.0052% | $0.27 | $13,680 | -36.39% | ||
2022-11-25 | Sale | director | 51,428 0.0051% | $0.31 | $15,752 | -44.94% | ||
2022-11-23 | Sale | director | 51,428 0.0046% | $0.33 | $16,971 | -53.33% | ||
2022-11-22 | Sale | director | 51,428 0.0044% | $0.20 | $10,106 | -25.27% | ||
2022-11-21 | President Global Sales | 60,000 0.0062% | $0.22 | $13,200 | -16.67% | |||
2022-11-18 | Officer | 1.25M 0.1312% | $0.20 | $250,000 | -5.56% | |||
2022-11-18 | director | 250,000 0.0262% | $0.20 | $50,000 | -5.56% | |||
2022-11-18 | President/Chief Bus. Officer | 250,000 0.0262% | $0.20 | $50,000 | -5.56% | |||
2022-09-16 | Chief Financial Officer | 60,000 0.0059% | $0.59 | $35,403 | -65.70% | |||
2022-09-12 | VP, Global HR | 12,782 0.0013% | $0.71 | $9,083 | -69.23% | |||
2022-08-30 | Chief Executive Officer | 37,500 0.0039% | $0.33 | $12,304 | -31.25% | |||
2022-05-24 | 40,000 0.004% | $0.64 | $25,720 | -53.31% | ||||
2022-05-20 | Chief Executive Officer | 65,000 0.007% | $0.75 | $48,750 | -57.30% | |||
2022-05-17 | President Global Sales | 10,000 0.0011% | $0.85 | $8,500 | -60.46% |
BARRY RICHARD SCOTT | 16337856 225.1858% | $0.43 | 2 | 0 | <0.0001% | |
EW Healthcare Partners, L.P. | 10 percent owner | 16337856 225.1858% | $0.43 | 2 | 0 | <0.0001% |
Kong Garheng | 6795621 93.6645% | $0.43 | 2 | 0 | <0.0001% | |
HealthQuest Partners II, L.P. | 10 percent owner | 6795621 93.6645% | $0.43 | 2 | 0 | <0.0001% |
Kliman Gilbert H | 5355786 73.8192% | $0.43 | 1 | 0 |